<DOC>
	<DOCNO>NCT00628953</DOCNO>
	<brief_summary>The purpose study assess efficacy safety Nexium treatment subject persistent asthma believe acid reflux contributory factor control asthma .</brief_summary>
	<brief_title>Adult Asthmatics Acid Reflux</brief_title>
	<detailed_description />
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Clinical diagnosis asthma Forced Expiratory Volume Peak Expiratory Flow define protocol Daily use inhale GCS and/or leukotriene pathway modifier great 3 month . Severe heartburn 3 days/week runin period . Subjects history 3 sinus infection treat antibiotic year prior Visit 1 . Any significant disease pathology judge clinically significant investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Acid Reflux</keyword>
	<keyword>Nexium</keyword>
	<keyword>Esomeprazole</keyword>
</DOC>